Izotropic Corporation (IZOZF)

0.1031 +0.0081 (+8.53%) At close: 01:55PM EDT

Izotropic Corporation

800 – 15355 24th Avenue
Suite 424
Surrey, BC V4A 2H9
Canada
833-496-2677
https://izocorp.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Robert Louis Thast	Founder, Interim CEO & Chairman	162.02k	N/A	1954
Mr. Ralph F. Proceviat CPA	Director & Interim CFO	N/A	N/A	1950
Dr. Younes Achkire Ph.D.	Executive VP of Product Engineering & COO	N/A	N/A	N/A
Mr. Ali Reza Sodagar	Legal Advisor & Independent Director	N/A	N/A	N/A
Ms. Jaclyn Thast	Operations Manager & Corporate Secretary	78.62k	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a 360-degree computed tomography imaging system designed for breast imaging. The company was incorporated in 2016 and is headquartered in Surrey, Canada.

Corporate Governance

Izotropic Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.